Bruno Carabelli

Bruno Carabelli

Auto-generated profile, based on publicly available information

Bruno Carabelli

A Laboratório de Neurofisiologia, Departamento de Fisiologia , Universidade Federal do Paraná , 81531-990 Curitiba , PR , Brazil

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2012 in CNS & Neurological Disorders - Drug Targets
Verified
Journal Article
Closed access
PDF file
MLMarcelo M.S. Lima
Marcelo M.S. Lima
EMEmerson F. Martins
Emerson F. Martins
ADAna Marcia Delattre
Ana Marcia Delattre
MPMariana B. Proenca
Mariana B. Proenca
MMMarco Mori
Marco Mori
AFAnete C. Ferraz
Anete C. Ferraz
Classically, Parkinson’s disease (PD) is considered to be a motor system affliction and its diagnosis is based on the presence of a set of cardinal motor signs (e.g. rigidity, bradykinesia, rest tremor and postural reflex disturbance). However, there is considerable evidence showing that non-motor alterations (e.g. anxiety, depression, sleep, gastrointestinal and cognitive functions) precede the classical motor symptoms seen in PD. The management of these nonmotor symptoms remains a challenge. A pattern of regional neurodegeneration that varies considerably depending upon the neuronal population affected may explain the different symptoms. In fact, differential mechanisms of neuronal vulnerability within the substantia nigra pars compacta (SNpc) suggests that factors other than location contribute to the susceptibility of these neurons. In this review we discuss how these factors interact to ultimately target the SNpc. Remarkably, this region consists of approximately 95% of the tyrosine hydroxylase (TH)-immunoreactive neurons in both human and rat brains, and consequently this implicates elevated levels of dopamine metabolites, free radicals and other hazard species in these neurons. An understanding of how these factors promote neuronal death may be useful for the development of novel neuroprotective and/or neurorestorative strategies for PD.

15 December 2015 in Molecular Neurobiology
Verified
Journal Article
Closed access
PDF file
IDIsabella Caroline Da Silva Dias
Isabella Caroline Da Silva Dias
BCBruno Carabelli
Bruno Carabelli
DIDaniela Kaori Ishii
Daniela Kaori Ishii
HMHelen De Morais
Helen De Morais
MCMilene Cristina De Carvalho
Milene Cristina De Carvalho
JZJanaina Menezes Zanoveli
Janaina Menezes Zanoveli

15 February 2017 in Nutritional Neuroscience
Verified
Journal Article
Closed access
MMMarco Mori
Marco Mori
ADAna Marcia Delattre
Ana Marcia Delattre
BCBruno Carabelli
Bruno Carabelli
CPClaudia Pudell
Claudia Pudell
MBMariza Bortolanza
Mariza Bortolanza
AFAnete Curte Ferraz
Anete Curte Ferraz
Objective: Parkinson's disease (PD) is characterized by deterioration of the nigrostriatal system and associated with chronic neuroinflammation. Glial activation has been associated with regulating the survival of dopaminergic neurons and is thought to contribute to PD through the release of proinflammatory and neurotoxic factors, such as reactive nitric oxide (NO) that triggers or exacerbates neurodegeneration in PD. Polyunsaturated fatty acids (PUFAs) exert protective effects, including antiinflammatory, antiapoptotic, and antioxidant activity, and may be promising for delaying or preventing PD by attenuating neuroinflammation and preserving dopaminergic neurons. The present study investigated the effects of fish oil supplementation that was rich in PUFAs on dopaminergic neuron loss, the density of inducible nitric oxide synthase (iNOS)-immunoreactive cells, and microglia and astrocyte reactivity in the substantia nigra pars compacta (SNpc) and striatal dopaminergic fibers. Methods: The animals were supplemented with fish oil for 50 days and subjected to unilateral intrastriatal 6-hydroxydopamine (6-OHDA)-induced lesions as a model of PD. Results: Fish oil mitigated the loss of SNpc neurons and nerve terminals in the striatum that was caused by 6-OHDA. This protective effect was associated with reductions of the density of iNOS-immunoreactive cells and microglia and astrocyte reactivity. Discussion: These results suggest that the antioxidant and antiinflammatory properties of fish oil supplementation are closely related to a decrease in dopaminergic damage that is caused by the 6-OHDA model of PD. GRAPHICAL ABSTRACT

6 November 2013 in European Journal of Neuroscience
Verified
Journal Article
Closed access
PDF file
CPClaudia Pudell
Claudia Pudell
BVBianca A. Vicente
Bianca A. Vicente
ADAna M. Delattre
Ana M. Delattre
BCBruno Carabelli
Bruno Carabelli
MMMarco Mori
Marco Mori
AFAnete C. Ferraz
Anete C. Ferraz

29 February 2016 in Molecular Neurobiology
Verified
Journal Article
Closed access
PDF file
ADAna Marcia Delattre
Ana Marcia Delattre
BCBruno Carabelli
Bruno Carabelli
MMMarco Mori
Marco Mori
PKPaula G. Kempe
Paula G. Kempe
LSLuiz E. Rizzo de Souza
Luiz E. Rizzo de Souza
AFAnete C. Ferraz
Anete C. Ferraz

20 August 2014 in Molecular Neurobiology
Verified
Journal Article
Closed access
PDF file
BCBruno Carabelli
Bruno Carabelli
ADAna Marcia Delattre
Ana Marcia Delattre
CPClaudia Pudell
Claudia Pudell
MMMarco Mori
Marco Mori
Deborah SucheckiDeborah Suchecki
Deborah Suchecki
AFAnete Curte Ferraz
Anete Curte Ferraz